Clinical trial

ALL-REZ BFM 2002: Multi-Center Study for Children With Relapsed Acute…

NCT00114348 · Charite University, Berlin, Germany, Other · Completed

Key facts

NCT number NCT00114348
Title ALL-REZ BFM 2002: Multi-Center Study for Children With Relapsed Acute Lymphoblastic Leukemia
Official title ALL-REZ BFM 2002: Protocol for the Treatment of Children With Relapsed Acute Lymphoblastic Leukemia
Lead sponsor Charite University, Berlin, Germany, Other
Collaborators Deutsche Kinderkrebsstiftung
Status Completed
Phase Phase 4
Study type Interventional
Conditions Lymphoblastic Leukemia, Acute, Lymphoma, Non-Hodgkin
Intervention type Procedure
Interventions R-Blocks, Protocol II-Ida
Enrollment 338
Start date Aug 1, 2003
Primary completion Jul 1, 2012
Completion Jul 1, 2012
First posted Jun 15, 2005
Last update posted Feb 4, 2013
Countries Germany

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies